In a major victory for health equity, Ugandan biotech firm DEI BioPharma has announced plans to manufacture Lenacapavir—a revolutionary HIV treatment recently approved by the U.S. Food and Drug Administration …
AfricaAFRICA NEWSHealthcareInformation & TechnologyInnovationTechnologyUGANDA